L1 Capital Global Opportunities Master Fund, Ltd. - 31 Mar 2025 SCHEDULE 13G/A Report for AEON Biopharma, Inc. Class A Common Stock, par value $0.0001 per share (AEON)
- Filing Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Reporting Manager
- L1 Capital Global Opportunities Master Fund, Ltd.
- Symbol
- AEON
- Shares outstanding
- 11,314,574 shares
- Disclosed Ownership
- 465,029 shares
- Ownership
- 4.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 19:21:07 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 13 Jan 2025
- SEC
- View on sec.gov
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| L1 Capital Global Opportunities Master Fund, Ltd. | 4.1% | 465,029 | 465,029 | 0 | /s/ David Feldman | David Feldman, Director |